Insiders Genprex, Inc.

Equities

GNPX

US3724462037

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-26 pm EDT			5-day change	1st Jan Change
2.21 ^USD	+4.25%		+3.76%	-75.98%

Apr. 03	Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa Therapy in Combination with Tecentriq to Treat Small Cell Lung Cancer	CI
Apr. 02	Genprex, Inc. Collaborators Publish Positive Preclinical Data with NPRL2 Gene Therapy Utilizing Oncoprex® Delivery System	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Genprex Appoints Suzanne Thornton-Jones as Senior Vice President, Regulatory Affairs	23-08-22	CI
Genprex, Inc. Announces Termination of Michael Redman as Operating Officer and Executive Vice President	21-10-15	CI
Genprex : Appoints Mark Berger Chief Medical Officer	21-09-28	MT
Genprex, Inc. Announces the Appointment of Mark S. Berger to the Position of Chief Medical Officer and Hemant Kumar to the Position of Chief Manufacturing and Technology Officer	21-09-28	CI
Genprex, Inc. Announces Formation of Clinical Advisory Board	21-02-08	CI
Genprex, Inc. Appoints George K. Gittes to Its Scientific Advisory Board	20-11-10	CI
Genprex : Shares Rise 13% After FDA Accepts Reqorsa Name for Cancer Treatment	20-10-29	DJ
Genprex, Inc. Receives Conditional FDA Acceptance of Proprietary Name Reqorsa™ for Lead Drug Candidate for Treatment of Non-Small Cell Lung Cancer	20-10-29	CI
Genprex, Inc. Promotes Eric Chapdelaine to Vice President of Manufacturing	20-10-26	CI
Genprex, Inc. Names Thomas C. Gallagher, Esq. as Senior Vice President of Intellectual Property and Licensing	20-09-21	CI
Genprex, Inc. Announces Appointment of J. Rodney Varner as President	20-08-14	CI
Genprex, Inc. Receives USAN Approval of Non-Proprietary Name for Lead Drug Candidate	20-06-25	CI
Genprex, Inc. Announces Resignation of Julien L. Pham as President and Chief Scientific Officer	20-04-28	CI
Genprex, Inc. Announces Board Resignations	20-04-21	CI
Genprex, Inc. Announces Board Appointments	20-03-24	CI
Genprex, Inc. Announces Executive Changes	20-03-23	CI
Genprex, Inc. Announces Resignation of John N. Bonfiglio as an Independent Director and Member of the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee of the Board	19-06-11	CI
Genprex, Inc. Appoints John N. Bonfiglio to its Board of Directors and Member of the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee	19-02-19	CI
Genprex, Inc. Appoints Jan Stevens, RN, as Vice President of Clinical Operations	18-10-30	CI
Genprex, Inc. Announces Executive Changes	18-04-11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Genprex, Inc.

Equities

GNPX

US3724462037

Insiders

Filters